Lilly Disappointed in Medicare Decision to Deny Appropriate Patient Access to Beta-Amyloid Imaging Agents, Including Amyvidâ¢ (Florbetapir F 18 Injection), Despite Support From Experts, Patients and the Alzheimer's Disease 